Sign inJoin waitlistJoin the waitlist

SS

Susan Slovin

Associate Vice Chair, Academic Affairs, Department of Medicine · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Academic Affairs · New York Presbyterian Hospital
Present

Weill Cornell Medical College
1997–1998
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1994–1997
Scripps Clinic & Research Foundation
1993–1994
Internal Medicine
Mount Sinai Hospital
1990–1993
Sidney Kimmel Medical College at Thomas Jefferson University
1986–1990

Research

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Journal of Clinical Oncology · 2016 · 1,422 citations
Organoid cultures derived from patients with advanced prostate cancer
Cell · 2014 · 1,236 citations
Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody
Science Translational Medicine · 2014 · 557 citations

HS
Howard Scher
75 papers
MM
Michael Morris
49 papers
WK
Wm Kelly
27 papers · 4 as a fellow
DR
Dana Rathkopf
26 papers
DD
Daniel Danila
18 papers
David Solit
15 papers · 2 as a fellow
PK
Philip Kantoff
15 papers
LS
Lawrence Schwartz
14 papers
SL
Steven Larson
14 papers
KA
Karen Autio
12 papers · 1 as a fellow
MC
Michael Carducci
11 papers
VR
Victor Reuter
11 papers

Grants

Cytokine Gene Therapy of Prostate Cancer
National Cancer Institute · R03
Contact PI · $77.1K · Sloan-Kettering Inst Can Research
1995–1999

Clinical trials

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Principal investigator · Terminated · Phase 3
Ferring Pharmaceuticals
2016–2021
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2014–2023
Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2010–2027
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2007–2010